utrogestan 300 mg
besins healthcare ireland limited (1) - progesteron - vaginalkapsel, myk - 300 mg
tolvaptan teva b.v. 30 mg / 90 mg
teva b.v. - tolvaptan - tablett - 30 mg / 90 mg
tolvaptan teva b.v. 30 mg / 60 mg
teva b.v. - tolvaptan - tablett - 30 mg / 60 mg
tolvaptan teva b.v. 45 mg / 15 mg
teva b.v. - tolvaptan - tablett - 45 mg / 15 mg
tibsovo
les laboratoires servier - ivosidenib - leukemia, myeloid, acute; cholangiocarcinoma - antineoplastiske midler - tibsovo in combination with azacitidine is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) with an isocitrate dehydrogenase-1 (idh1) r132 mutation who are not eligible to receive standard induction chemotherapy (see section 5. tibsovo monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with an idh1 r132 mutation who were previously treated by at least one prior line of systemic therapy.
orserdu
stemline therapeutics b.v. - elacestrant - bryst neoplasms - endokrin terapi - orserdu monotherapy is indicated for the treatment of postmenopausal women, and men, with estrogen receptor (er) positive, her2-negative, locally advanced or metastatic breast cancer with an activating esr1 mutation who have disease progression following at least one line of endocrine therapy including a cdk 4/6 inhibitor.
instanyl 100 mikrog/ dose
orifarm as - fentanyl - nesespray, oppløsning - 100 mikrog/ dose
instanyl 200 mikrog/ dose
orifarm as - fentanyl - nesespray, oppløsning - 200 mikrog/ dose
bosulif 400 mg
abacus medicine a/s - bosutinibmonohydrat - tablett, filmdrasjert - 400 mg
bosulif 100 mg
2care4 aps - bosutinibmonohydrat - tablett, filmdrasjert - 100 mg